| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 293,603 | 306,894 | 310,643 | 301,768 | | Cost of Revenue |
-
|
-
|
-
| (211,323) | | | Gross Profit | 293,603 | 306,894 | 310,643 | 513,091 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 189,813 | 209,889 | 224,991 | 417,166 | | Non Recurring | 28,665 | (20,730) | 20,730 |
-
| | Others | (19,608) | 29,671 | 4,873 | 10,168 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 94,733 | 88,064 | 60,049 | 85,757 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 157 | (269) | (1,926) | (6,391) | | Earnings Before Interest And Taxes | 94,890 | 87,795 | 58,123 | 78,111 | | Interest Expense |
-
|
-
|
-
| (3,193) | | Income Before Tax | 94,890 | 87,795 | 58,123 | 81,304 | | Income Tax Expense | 34,604 | 31,712 | 20,654 | 27,042 | | Minority Interest |
-
|
-
|
-
| (1,255) | | | | Net Income From Continuing Ops | 60,286 | 56,083 | 37,469 | 54,262 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 60,286 | 56,083 | 37,469 | 54,262 | | Preferred Stock And Other Adjustments | (3,301) | (2,809) | (2,334) |
-
| | | Net Income Applicable To Common Shares | $56,985 | $53,274 | $35,135 | $54,262 |
|
0.11% Nasdaq 
Income Statement
